The Past, Present, and Future of HER2 ( ERBB2 ) in Cancer: Approaches to Molecular Testing and an Evolving Role in Targeted Therapy

Cancer cytopathology - United States
doi 10.1002/cncy.22124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

IGF-IR Targeted Therapy: Past, Present and Future

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Past, Present, and Future of Hormonal Therapy in Recurrent Endometrial Cancer

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2014English

Targeted Lapatinib Anti-Her2/ErbB2 Therapy Resistance in Breast Cancer: Opportunities to Overcome a Difficult Problem

2020English

Motor Control and the Role of Occupational Therapy: Past, Present, and Future

American Journal of Occupational Therapy
MedicineOccupational Therapy
1989English

Antiplatelet Therapy in Cardiovascular Disease – Past, Present and Future

2012English

Thyroid Hormone Therapy: Past, Present, and Future

Endocrine
2019English

Past, Present, and Future Challenges in Breast Cancer Treatment

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Lung Cancer Screening: Past, Present and Future

Frontiers in Respiratory Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy